Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1984-04-17
1985-03-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
A61K 3578
Patent
active
045044732
ABSTRACT:
A pharmaceutical composition is disclosed comprising a purified pyridine-soluble extract obtained from microorganism which contains between about 7 and 20% by weight of protein, between about 10 and 16% by weight of sugar, and between about 35 and 55% by weight of fatty acids which when combined with trehalose dimycolate and an acetone precipitated by-product of endotoxic glycol lipids extracted with chloroform-methanol in a pharmaceutically acceptable medium is useful as an anti-animal tumor agent in the treatment of animals.
REFERENCES:
patent: 3956481 (1976-05-01), Jolles et al.
patent: 3976544 (1976-08-01), Adam et al.
Meyer et al., J. Natl. Can. Inst. 52: 103-108, 1974.
Ribi et al., Natl. Can. Inst., Monograph, No. 39, 1974.
Rozencweig et al., Canc., 40: 334-342, 1977.
Pharmacological Basis of Cancer Chem., Williams & Wilkins Co., 1975, pp. 245-270.
Goldberg Jerome D.
Ribi ImmunoChem Research Inc.
Rollins John W.
LandOfFree
Pyridine soluble extract of a microorganism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine soluble extract of a microorganism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine soluble extract of a microorganism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-707568